Intrapleural Hyaluronidase in Viscous Malignant Mesothelioma Pleural Effusion

Chest. 2021 Dec;160(6):e609-e611. doi: 10.1016/j.chest.2021.07.031.

Abstract

Malignant pleural effusion is common in mesothelioma. We report a case of viscous recurrent malignant mesothelioma pleural effusion. The viscosity was due to the presence of hyaluronic acid and resulted in prolonged drainage time. The use of intrapleural hyaluronidase significantly reduced fluid viscosity and drainage duration. No adverse reactions were noted. This novel case highlights the feasibility and safety of the use of intrapleural hyaluronidase in the management of hyaluronic acid-rich viscous malignant pleural effusion.

Keywords: hyaluronic acid; hyaluronidase; malignant pleural effusion; mesothelioma; viscous pleural effusion.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Combined Modality Therapy
  • Drainage
  • Exudates and Transudates / drug effects*
  • Humans
  • Hyaluronoglucosaminidase / therapeutic use*
  • Male
  • Mesothelioma, Malignant / therapy*
  • Pleural Effusion, Malignant / therapy*
  • Pleural Neoplasms / therapy*

Substances

  • Hyaluronoglucosaminidase